Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Non-Current Assets (2018 - 2025)

Historic Non-Current Assets for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to $41.8 million.

  • Precision Biosciences' Non-Current Assets fell 217.62% to $41.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $164.2 million, marking a year-over-year increase of 4680.65%. This contributed to the annual value of $41.4 million for FY2024, which is 7675.26% up from last year.
  • According to the latest figures from Q3 2025, Precision Biosciences' Non-Current Assets is $41.8 million, which was down 217.62% from $38.7 million recorded in Q2 2025.
  • Precision Biosciences' Non-Current Assets' 5-year high stood at $49.7 million during Q4 2021, with a 5-year trough of $18.5 million in Q3 2023.
  • Moreover, its 5-year median value for Non-Current Assets was $41.8 million (2025), whereas its average is $38.2 million.
  • Per our database at Business Quant, Precision Biosciences' Non-Current Assets plummeted by 6011.9% in 2023 and then soared by 13109.99% in 2024.
  • Quarter analysis of 5 years shows Precision Biosciences' Non-Current Assets stood at $49.7 million in 2021, then fell by 21.47% to $39.1 million in 2022, then crashed by 40.04% to $23.4 million in 2023, then soared by 76.75% to $41.4 million in 2024, then rose by 0.98% to $41.8 million in 2025.
  • Its Non-Current Assets was $41.8 million in Q3 2025, compared to $38.7 million in Q2 2025 and $42.3 million in Q1 2025.